Board of Directors

The members of the Board of Directors comprise a group of professionally skilled business people representing a diversity and experience within animal health and life sciences, key competence areas for vaccine development. Current members are:
Bengt Guss
Bengt Guss

Professor at the Swedish University of Agricultural Sciences, Department of Biomedical Sciences and Veterinary Public Health.
Independent of
The company and its executives.

Independent of
major shareholders.

Member since 2001

Marianne Hansson

CEO in start-ups ScandiBio Therapeutics AB, ScandiEdge Therapeutics AB and Amylonix AB. Former CEO at Atlas Antibodies AB
Independent of
The company and its executives.

Independent of
major shareholders.

Member since 2018

Niels Holcke

DVM, Diploma in Business Economics.
Former Business Unit Director, Orion Pharma Animal Health
Long experience as chairman and board member of the Veterinary Industry Association in Denmark,
and board member of FEDESA, The European Federation of Animal Health

Independent of
The company and its executives.

Independent of
major shareholders.

Member since 2020

Björn Sjöstrand

Chairman of the board, CEO Scandinavian Biopharma, former CEO of SBL Vaccin in Sweden, CEO of Swiss Berna Biotech and global head of the vaccines division of the Dutch company Crucell.
Independent of
The company and its executives.

Independent of
major shareholders.

Member since 2020

Stefan Ståhl

Professor at the Royal Institute of Technology, department of molecular biotechology.
Independent of
The company and its executives.

Independent of
major shareholders.

Member since 2009

Ed Torr

Chairman of the Remuneration and Nomination Committee Animalcare Group plc. and chairman Agrimin Ltd.
Former executive director on the board of Dechra and Managing Director of Dechra Veterinary Products Europe

Independent of
The company and its executives.

Independent of
major shareholders.

Member since 2020